Pfizer Canada strives to profoundly impact the health of Canadians through the discovery, development and delivery of medicines and vaccines. Our diverse portfolio offers a broad range of benefits and solutions to meet the needs of Canadians.
09.28.2023
Pfizer and BioNTech Receive Health Canada Authorization for XBB.1.5-Adapted Monovalent COVID-19 Vaccine
07.31.2023
Rethink Breast Cancer and Pfizer Canada announce recipients of the 2023 national quality improvement grants to support metastatic breast cancer patients